Anabios Corp
Anabios Corporation
- UEI
- P3N4G7B5SRA7
- CAGE
- 631Z6
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- anabios.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Consumer Discretionary
- Consumer Services
- Diversified Consumer Services
- Specialized Consumer Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel analgesic for mixed inflammatory and neuropathic pain states - abstract in 2017, more than 47,000… | National Institute of Neurological Disorders and Stroke | $6,625,632 | |
| 01-dorsal root ganglia (DRG) from pain donors | National Institute of Dental and Craniofacial Research | $24,975 | |
| Development of a novel translational pain-drug screening platform for the generation of human-relevant data in… | National Institute on Drug Abuse | $320,054 | |
| Development of an integrated platform for the use of adult human primary cardiomyocytes in preclinical safety assessment | National Center for Advancing Translational Sciences | $1,132,289 | |
| Task order 1: services to provide electrophysiological and contractility assessment of drugs on primary adult… | Food and Drug Administration | $249,708 |
About Anabios Corp
Anabios Corporation is a translational research company that provides human-based testing services and data to support the development of promising new therapies. Through federal contracts and grants, the company generates predictive data on drug effects and safety using human primary cell models.
Anabios has provided human dorsal root ganglia samples, human ventricular cardiomyocyte testing services, and other specialized bioassay services to federal agencies including the NIH, FDA, and NCATS. These services, provided both as a prime contractor and subcontractor, support federal research programs related to pain, addiction, cardiology, and drug development. Services are provided on a fee-for-service basis without any small business set-aside designations.
Anabios has also received federal grants to develop new research platforms and biomarkers using its human primary cell technologies. Grants were awarded by the NINDS, NIDA, and FDA to advance translational pain drug screening methods, cardiac safety testing protocols, and proarrhythmia risk biomarkers based on human cardiomyocyte contractility. These programs aim to improve the predictive value of preclinical data and the translational success of new pain and cardiac therapies.
Additionally, Anabios holds an IDIQ contract from the FDA to provide electrophysiology and contractility testing services on human ventricular cardiomyocytes. This $500,000 IDIQ contract covers specialized bioassay services over a one-year period to support the FDA's evaluation of drug effects on cardiac function. Task orders under this contract vehicle are awarded on a firm fixed price basis.
Quick answers
What is Anabios Corp's UEI?
Anabios Corp's Unique Entity ID (UEI) in SAM.gov is P3N4G7B5SRA7.
What is Anabios Corp's CAGE code?
Anabios Corp's CAGE code is 631Z6.
What is Anabios Corp's primary NAICS code?
Anabios Corp's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Anabios Corp registered in SAM.gov?
Anabios Corp's SAM.gov registration expired on September 17, 2025.
What is Anabios Corp's most recent federal award?
Anabios Corp's most recent federal grant award is Development of a novel analgesic for mixed inflammatory and neuropathic pain states - abstract in 2017, more than 47,000… (R44NS119036), from National Institute of Neurological Disorders and Stroke, on September 15, 2021.
On GovTribe
See Anabios Corp's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors